Wundrsight Health

Founded by Nishtha “Nish” Budhiraja (Co-Founder & Chief Medical Officer) with her co-founder Raunak Swarnkar , Wundrsight Health is building a clinician-led, AI-powered VR digital therapeutics platform for mental health and neurodevelopment. The team’s focus is simple: make therapy more engaging, more measurable, and easier to deliver—especially for populations that are often underserved, including neurodivergent children (autism, ADHD, learning differences) and people living with mental health conditions that require structured therapy support.

What are they building?

Wundrsight builds clinician-led VR therapy programs designed to complement human care, improve engagement, and help clinics scale support. Its VR solutions are designed for psychologists, occupational therapists, physiotherapists, and other trained professionals, with a growing portfolio of programs across mental health needs as listed publicly by the company. Wundrsight also offers BoostXR™ , a VR therapy platform created for neurodiverse children that can be used in clinics, classrooms, or homes, supporting skills development through immersive and personalized sessions.

Overall, the model is built to improve access and delivery through more scalable workflows and monitoring.

The why?

Wundrsight VR Neuro-Rehab Demo at HOSMAT Hospitals

For Nishta, this started long before the company did.

In 2015, while studying cognitive neuropsychology in the UK, she was introduced to VR—at a time when it was mostly confined to labs and research. She built a clinical experiment using a video game approach for phobia work, and it stayed with her. Years later, after repeated conversations with her future co-founder about building a “digital revolution” for mental health in India, the real proof came during the first lockdown: they spoke to around 150 mental health professionals and heard the same thing—burnout, limited tools, and a system struggling to scale.

Then came the moment that made it undeniable.

Nish describes working with a 12-year-old child diagnosed with PTSD who was terrified of thunderstorms. After teaching breathwork and somatic safety, she used VR desensitization in a rain simulation—outside, in a garden—when it happened to be raining and thundering in real life too. She still remembers it vividly: “Quite frankly, it still gives me goosebumps.” That was in 2022, before incorporation, using a basic prototype—and the child never returned with the same anxiety again.

SEED Inclusivity Program Journey

Wundrsight came into SEED Inclusivity already comfortable using AI. Nish describes it as an “executive assistant” for paperwork, so SIGMA wasn’t intimidating. What really clicked were the platform’s visual frameworks, which helped her process decisions faster, especially the graphic that maps ideas like quick wins vs. moonshots.

One immediate takeaway was messaging and go-to-market clarity. The team had been debating whether selling BoostXR primarily through therapy centers was the best approach, and SIGMA helped articulate what they were already sensing: parent awareness and parent pathways matter.

She also shared a practical inclusivity critique. Action points would be even easier to follow if SIGMA consistently showed which persona each one is tied to, since switching perspectives (parent vs. clinician vs. child) adds extra steps for neurodivergent users.

Beyond the tool, she described the Seedstars bootcamp experience as unusually thoughtful, down to dietary accessibility, and said it created an environment where founders feel genuinely “seen.”

Recent Achievements

Raised $400K seed funding led by Inflection Point Ventures , with Social Alpha and angel investors participating (announced Sept 2024).

Expanding delivery through hospital and clinic partnerships across India.

Built a growing portfolio of VR digital therapeutics , including programs publicly listed as ReliefXR (stress) , ResistXR (OCD) , and ReviveXR (substance use disorders) .

Launched BoostXR™ , a VR therapy platform positioned for neurodiverse children (including ADHD, ASD, and learning differences ) across clinic, classroom, and home settings.

“And that is the one therapy session that stuck with me… The parents have never given me a call saying that, ‘hey, he’s still getting anxious.’”

— Nishtha “Nish” Budhiraja, Co-Founder & CMO